<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04219800</url>
  </required_header>
  <id_info>
    <org_study_id>2019-05383</org_study_id>
    <nct_id>NCT04219800</nct_id>
  </id_info>
  <brief_title>Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)</brief_title>
  <acronym>ROSEBUD</acronym>
  <official_title>Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norrbottens County Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vastra Gotaland Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Östergötland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stockholm County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Region Örebro County</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes mellitus (T2DM) patients are suboptimal treated due to low uptake of physical
      activity. Recent research shows promising beneficial health effects from reducing sitting
      time by regular short bouts of light-intensity physical activity. These findings open up for
      a new focus in T2DM treatment but conclusive evidence is missing as studies have been
      short-term trials, mainly conducted in laboratory environments. Recent research suggest that
      reduced sitting and increased physical activity can be supported at a low cost by mHealth
      (mobile health) technology such as activity tracker armbands that warns of prolonged sitting
      and SMS text messages that reminds of activity breaks.

      The overarching purpose of the project is to evaluate the effects of an intervention aimed to
      reduce occupational sitting in T2DM using mHealth (mobile health). It is hypothesized that
      the intervention will lead to (1) Activity changes - reduced sitting time and/or increased
      number of steps (primary outcome measures) and (2) Health effects - lower fatigue, improved
      health-related quality of life, reduced cardiometabolic risk, less sick leave, less
      medication, less musculoskeletal problems (secondary outcome measures)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sitting time</measure>
    <time_frame>12 months</time_frame>
    <description>Assessed by activPAL3 thigh-worn accelerometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Steps</measure>
    <time_frame>12 months</time_frame>
    <description>Assessed by activPAL3 thigh-worn accelerometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>12 months</time_frame>
    <description>MFI-20 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>RAND-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiometabolic composite score (CCMR)</measure>
    <time_frame>12 months</time_frame>
    <description>Will be determined by summing z-scores ([value−mean]/SD) of waist circumference (cm), mean arterial pressure (mmHg), HbA1c (mmol/mol), the inverse of HDL (mmol/L) and triglycerides (mmol/L), using sex-specific means and SDs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sick leave</measure>
    <time_frame>12 months</time_frame>
    <description>Assessed by diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medications</measure>
    <time_frame>12 months</time_frame>
    <description>Total use of medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Musculoskeletal problems</measure>
    <time_frame>12 months</time_frame>
    <description>NRS questionnaire</description>
  </secondary_outcome>
  <other_outcome>
    <measure>General self-efficacy</measure>
    <time_frame>12 months</time_frame>
    <description>GSE-10 questionnaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">142</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>mHealth</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps.
SMS text messages; reminds of activity breaks.
Mobile video instruction for standing pause gymnastics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient-centered counselling and written material</intervention_name>
    <description>Patient-centered counselling and written material regarding occupational sedentary behaviour, with telephone follow-ups after 1 and 5 weeks.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>mHealth</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>mHealth</intervention_name>
    <description>Activity tracker armband (Garmin Vivofit); warns of prolonged sitting and counts daily steps.
SMS text messages; reminds of activity breaks.
Mobile video instruction for standing pause gymnastics.</description>
    <arm_group_label>mHealth</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 Diabetes Melltitus

          -  40-64 years

          -  HbA1c 53-100 mmol/mol

          -  BMI ≥ 25 kg/m2

          -  Working at least 75% of full-time in a mainly seated job.

        Exclusion Criteria:

          -  Pregnancy

          -  Regular vigorous intensity exercise

          -  Severe disease or for other reason unable to follow the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrik Wennberg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Umeå University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrik Wennberg</last_name>
    <phone>+46907869450</phone>
    <email>patrik.wennberg@umu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Brännholm Syrjälä</last_name>
    <email>maria.brannholm-syrjala@norrbotten.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hertsöns Hälsocentral</name>
      <address>
        <city>Luleå</city>
        <state>Norrbotten</state>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Nordendahl, Dr</last_name>
      <email>maria.nordendahl@umu.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 2, 2020</study_first_submitted>
  <study_first_submitted_qc>January 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Umeå University</investigator_affiliation>
    <investigator_full_name>Patrik Wennberg</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

